Senseonics Holdings, Inc. (SENS)
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?
Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership
SENS partners with Welldoc on a next-gen Eversense 365 app, adding Apple Health/Google Health Connect integration ahead of the U.S. launch.
Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript
Senseonics Holdings, Inc. (SENS) Shareholder/Analyst Call Transcript
Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights
Senseonics Holdings, Inc. Common Stock NASDAQ: SENS raised its full-year 2026 revenue outlook after reporting first-quarter growth tied to adoption of its Eversense 365 continuous glucose monitoring system and the integration of its U.S. commercial organization.
Senseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call Transcript
Senseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call Transcript
Senseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue Estimates
Senseonics Holdings (SENS) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to a loss of $0.4 per share a year ago.
SENS Launches Eversense 365, World's Only One-Year CGM in Europe
Senseonics launches Eversense 365 in Europe, debuting the first year-long CGM system as it expands into key markets and targets millions of new patients.
Senseonics Reports Strong One-Year Real-World Data for Eversense 365
SENS highlights strong one-year real-world data for Eversense 365, reinforcing adherence, glucose control and long-term adoption potential.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and two
Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS): Here's What You Should Know
The consensus price target hints at a 124.5% upside potential for Senseonics (SENS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript
Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
Senseonics Holdings (SENS) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago.
